Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation.

Goërtz YMJ, Spruit MA, Van 't Hul AJ, Peters JB, Van Herck M, Nakken N, Djamin RS, Burtin C, Thong MSY, Coors A, Meertens-Kerris Y, Wouters EFM, Prins JB, Franssen FME, Muris JWM, Vanfleteren LEGW, Sprangers MAG, Janssen DJA, Vercoulen JH.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619878128. doi: 10.1177/1753466619878128.

2.

Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.

Canepa M, Franssen FME, Olschewski H, Lainscak M, Böhm M, Tavazzi L, Rosenkranz S.

JACC Heart Fail. 2019 Oct;7(10):823-833. doi: 10.1016/j.jchf.2019.05.009. Epub 2019 Sep 11. Review.

PMID:
31521680
3.

Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure.

Franssen FME, Vanfleteren LEGW, Janssen DJA, Wouters EFM, Spruit MA.

Breathe (Sheff). 2019 Sep;15(3):227-233. doi: 10.1183/20734735.0186-2019.

4.

Personalized medicine for patients with COPD: where are we?

Franssen FM, Alter P, Bar N, Benedikter BJ, Iurato S, Maier D, Maxheim M, Roessler FK, Spruit MA, Vogelmeier CF, Wouters EF, Schmeck B.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 9;14:1465-1484. doi: 10.2147/COPD.S175706. eCollection 2019.

5.

Low Vitamin K Status Is Associated with Increased Elastin Degradation in Chronic Obstructive Pulmonary Disease.

Piscaer I, van den Ouweland JMW, Vermeersch K, Reynaert NL, Franssen FME, Keene S, Wouters EFM, Janssens W, Vermeer C, Janssen R.

J Clin Med. 2019 Jul 27;8(8). pii: E1116. doi: 10.3390/jcm8081116.

6.

Optimizing health in chronic lung diseases: What did we learn from the experts in pulmonary rehabilitation?

Alison JA, Franssen FME.

Respirology. 2019 Sep;24(9):916-917. doi: 10.1111/resp.13638. Epub 2019 Jul 15. No abstract available.

7.

The superexacerbator phenotype in patients with COPD: a descriptive analysis.

Vanfleteren LEGW, Boonen LMC, Spruit MA, Janssen DJA, Wouters EFM, Franssen FME.

ERJ Open Res. 2019 Jun 4;5(2). pii: 00235-2018. doi: 10.1183/23120541.00235-2018. eCollection 2019 Apr.

8.

Airflow Obstruction and Cardio-metabolic Comorbidities.

Triest FJJ, Studnicka M, Franssen FME, Vollmer WM, Lamprecht B, Wouters EFM, Burney PGJ, Vanfleteren LEGW.

COPD. 2019 Apr;16(2):109-117. doi: 10.1080/15412555.2019.1614550. Epub 2019 May 27.

PMID:
31131642
9.

Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).

Oshagbemi OA, Franssen FME, van Kraaij S, Braeken DCW, Wouters EFM, Maitland-van der Zee AH, Driessen JHM, de Vries F.

COPD. 2019 Apr;16(2):152-159. doi: 10.1080/15412555.2019.1608172. Epub 2019 May 23.

PMID:
31117850
10.

Disease-Specific Comorbidity Clusters in COPD and Accelerated Aging.

Triest FJJ, Franssen FME, Reynaert N, Gaffron S, Spruit MA, Janssen DJA, Rutten EPA, Wouters EFM, Vanfleteren LEGW.

J Clin Med. 2019 Apr 14;8(4). pii: E511. doi: 10.3390/jcm8040511.

11.

Revealing Methodological Challenges in Chronic Obstructive Pulmonary Disease Studies Assessing Comorbidities: A Narrative Review.

Houben-Wilke S, Triest FJJ, Franssen FME, Janssen DJA, Wouters EFM, Vanfleteren LEGW.

Chronic Obstr Pulm Dis. 2019 Apr 9;6(2):166-177. doi: 10.15326/jcopdf.6.2.2018.0145. Epub 2019 Apr 9. Review.

12.

Clinical outcome and cost-effectiveness of a 1-year nutritional intervention programme in COPD patients with low muscle mass: The randomized controlled NUTRAIN trial.

van Beers M, Rutten-van Mölken MPMH, van de Bool C, Boland M, Kremers SPJ, Franssen FME, van Helvoort A, Gosker HR, Wouters EF, Schols AMWJ.

Clin Nutr. 2019 Mar 18. pii: S0261-5614(19)30114-1. doi: 10.1016/j.clnu.2019.03.001. [Epub ahead of print]

13.

Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD.

Sprooten RTM, Rohde GGU, Lawyer G, Leijte WT, Wouters EFM, Franssen FME.

Respirology. 2019 Aug;24(8):765-776. doi: 10.1111/resp.13538. Epub 2019 Mar 21.

PMID:
30897284
14.

Pulmonary rehabilitation, physical activity, respiratory failure and palliative respiratory care.

Spruit MA, Rochester CL, Pitta F, Kenn K, Schols AMWJ, Hart N, Wouters EFM, Nava S, Dreher M, Janssen DJA, Johnson MJ, Curtis RJ, Sastry M, Franssen FME.

Thorax. 2019 Jul;74(7):693-699. doi: 10.1136/thoraxjnl-2018-212044. Epub 2019 Mar 14.

PMID:
30872364
15.

Rehabilitation in chronic respiratory diseases: Live your life to the max.

Franssen FME, Alison JA.

Respirology. 2019 Sep;24(9):828-829. doi: 10.1111/resp.13511. Epub 2019 Feb 26. No abstract available.

16.

European Respiratory Society International Congress, Paris, 2018: highlights from the Clinical Assembly.

Vanfleteren LEGW, Ojanguren I, Nolan CM, Franssen FME, Andrianopoulos V, Grgic A, van Dijk M, Slebos DJ, Daines L, Kocks JWH, Kahn N.

ERJ Open Res. 2019 Feb 11;5(1). pii: 00176-2018. doi: 10.1183/23120541.00176-2018. eCollection 2019 Feb. Review.

17.

Emphysema: looking beyond alpha-1 antitrypsin deficiency.

Janssen R, Piscaer I, Franssen FME, Wouters EFM.

Expert Rev Respir Med. 2019 Apr;13(4):381-397. doi: 10.1080/17476348.2019.1580575. Epub 2019 Feb 22.

PMID:
30761929
18.

Clinical impact of body composition phenotypes in patients with COPD: a retrospective analysis.

Machado FVC, Schneider LP, Fonseca J, Belo LF, Bonomo C, Morita AA, Furlanetto KC, Felcar JM, Rodrigues A, Franssen FME, Spruit MA, Pitta F, Hernandes NA.

Eur J Clin Nutr. 2019 Jan 14. doi: 10.1038/s41430-019-0390-4. [Epub ahead of print]

PMID:
30643222
19.

Comprehensive Lung Function Assessment Does not Allow to Infer Response to Pulmonary Rehabilitation in Patients with COPD.

Augustin IML, Wouters EFM, Houben-Wilke S, Gaffron S, Janssen DJA, Franssen FME, Spruit MA.

J Clin Med. 2018 Dec 27;8(1). pii: E27. doi: 10.3390/jcm8010027.

20.

Impact of pulmonary rehabilitation on activities of daily living in patients with chronic obstructive pulmonary disease.

Vaes AW, Delbressine JML, Mesquita R, Goertz YMJ, Janssen DJA, Nakken N, Franssen FME, Vanfleteren LEGW, Wouters EFM, Spruit MA.

J Appl Physiol (1985). 2019 Mar 1;126(3):607-615. doi: 10.1152/japplphysiol.00790.2018. Epub 2018 Nov 29.

PMID:
30496707
21.

Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores.

Houben-Wilke S, Janssen DJA, Franssen FME, Vanfleteren LEGW, Wouters EFM, Spruit MA.

Health Qual Life Outcomes. 2018 Oct 30;16(1):205. doi: 10.1186/s12955-018-1034-4.

22.

Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013.

Oshagbemi OA, Keene SJ, Driessen JHM, Jordan R, Wouters EFM, de Boer A, de Vries F, Franssen FME.

Respir Med. 2018 Nov;144:1-6. doi: 10.1016/j.rmed.2018.09.010. Epub 2018 Sep 17.

PMID:
30366578
23.

Chronic Obstructive Pulmonary Disease: Shifting the Paradigm to the Vasculature.

Wouters EFM, Franssen FM.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):258-259. doi: 10.1164/rccm.201808-1542ED. No abstract available.

PMID:
30265129
24.

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality.

Oshagbemi OA, Franssen FME, Braeken DCW, Henskens Y, Wouters EFM, Maitland-van der Zee AH, Burden AM, de Vries F.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1191-1199. doi: 10.1002/pds.4655. Epub 2018 Sep 28.

25.

The respiratory physiome: Clustering based on a comprehensive lung function assessment in patients with COPD.

Augustin IML, Spruit MA, Houben-Wilke S, Franssen FME, Vanfleteren LEGW, Gaffron S, Janssen DJA, Wouters EFM.

PLoS One. 2018 Sep 12;13(9):e0201593. doi: 10.1371/journal.pone.0201593. eCollection 2018.

26.

Inhaled corticosteroids in COPD: friend or foe?

Agusti A, Fabbri LM, Singh D, Vestbo J, Celli B, Franssen FME, Rabe KF, Papi A.

Eur Respir J. 2018 Dec 13;52(6). pii: 1801219. doi: 10.1183/13993003.01219-2018. Print 2018 Dec. Review.

PMID:
30190269
27.

The physical, mental, and social impact of COPD in a population-based sample: results from the Longitudinal Aging Study Amsterdam.

Franssen FME, Smid DE, Deeg DJH, Huisman M, Poppelaars J, Wouters EFM, Spruit MA.

NPJ Prim Care Respir Med. 2018 Aug 10;28(1):30. doi: 10.1038/s41533-018-0097-3.

28.

Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.

Polkey MI, Praestgaard J, Berwick A, Franssen FME, Singh D, Steiner MC, Casaburi R, Tillmann HC, Lach-Trifilieff E, Roubenoff R, Rooks DS.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):313-320. doi: 10.1164/rccm.201802-0286OC.

29.

Effectiveness of Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease With Different Degrees of Static Lung Hyperinflation.

Vanfleteren MJ, Koopman M, Spruit MA, Pennings HJ, Smeenk F, Pieters W, van den Bergh JJ, Michels AJ, Wouters EF, Groenen MT, Franssen FM, Vanfleteren LE.

Arch Phys Med Rehabil. 2018 Nov;99(11):2279-2286.e3. doi: 10.1016/j.apmr.2018.05.011. Epub 2018 Jun 12.

PMID:
29906421
30.

COPD patient education and support - Achieving patient-centredness.

Stoilkova-Hartmann A, Franssen FME, Augustin IML, Wouters EFM, Barnard KD.

Patient Educ Couns. 2018 Nov;101(11):2031-2036. doi: 10.1016/j.pec.2018.05.024. Epub 2018 Jun 1.

PMID:
29884533
31.

COPD stands for complex obstructive pulmonary disease.

Houben-Wilke S, Augustin IM, Vercoulen JH, van Ranst D, Bij de Vaate E, Wempe JB, Spruit MA, Wouters EFM, Franssen FME.

Eur Respir Rev. 2018 Jun 6;27(148). pii: 180027. doi: 10.1183/16000617.0027-2018. Print 2018 Jun 30. Review.

32.

Looking into the eye of patients with chronic obstructive pulmonary disease: an opportunity for better microvascular profiling of these complex patients.

Vaes AW, Spruit MA, Theunis J, Goswami N, Vanfleteren LE, Franssen FME, Wouters EFM, De Boever P.

Acta Ophthalmol. 2018 Sep;96(6):539-549. doi: 10.1111/aos.13765. Epub 2018 May 16. Review.

33.

Determinants of functional, peak and endurance exercise capacity in people with chronic obstructive pulmonary disease.

McNamara RJ, Houben-Wilke S, Franssen FME, Smid DE, Vanfleteren LEGW, Groenen MTJ, Uszko-Lencer NHMK, Wouters EFM, Alison JA, Spruit MA.

Respir Med. 2018 May;138:81-87. doi: 10.1016/j.rmed.2018.03.032. Epub 2018 Mar 29.

PMID:
29724398
34.

Personalised pulmonary rehabilitation in COPD.

Wouters EFM, Wouters BBREF, Augustin IML, Houben-Wilke S, Vanfleteren LEGW, Franssen FME.

Eur Respir Rev. 2018 Mar 28;27(147). pii: 170125. doi: 10.1183/16000617.0125-2017. Print 2018 Mar 31. Review.

35.

Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease.

Oshagbemi OA, Burden AM, Shudofsky KN, Driessen JHM, Vestergaard P, Krings A, Franssen FME, van den Bergh J, de Vries F.

Bone. 2018 May;110:238-243. doi: 10.1016/j.bone.2018.02.007. Epub 2018 Feb 17.

PMID:
29462672
36.

European Respiratory Society International Congress 2017: highlights from the Clinical Assembly.

Kahn N, Mekov E, Fregonese L, Andrianopoulos V, Franssen FME, Grgic A, Coolen J, Bonta PI, Gompelmann D, Annema JT, Faverio P, Bonella F, Daines L, Pinnock H, Kocks J, Herth F.

ERJ Open Res. 2018 Jan 10;4(1). pii: 00134-2017. doi: 10.1183/23120541.00134-2017. eCollection 2018 Jan.

37.

An old debate still in the β-phase?

Barandiarán Aizpurua A, Franssen FME, van Empel V, Brunner-La Rocca HP.

Eur J Heart Fail. 2018 Mar;20(3):557-559. doi: 10.1002/ejhf.1086. Epub 2018 Jan 12. No abstract available.

38.

Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?

Spruit MA, Singh SJ, Rochester CL, Greening NJ, Franssen FME, Pitta F, Troosters T, Nolan C, Vogiatzis I, Clini EM, Man WD, Burtin C, Goldstein RS, Vanfleteren LEGW, Kenn K, Nici L, Janssen DJA, Casaburi R, Shioya T, Garvey C, Carlin BW, ZuWallack RL, Steiner M, Wouters EFM, Puhan MA.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701312. doi: 10.1183/13993003.01312-2017. Print 2018 Jan. No abstract available.

39.

Spatiotemporal gait characteristics in patients with COPD during the Gait Real-time Analysis Interactive Lab-based 6-minute walk test.

Liu WY, Spruit MA, Delbressine JM, Willems PJ, Franssen FME, Wouters EFM, Meijer K.

PLoS One. 2017 Dec 28;12(12):e0190099. doi: 10.1371/journal.pone.0190099. eCollection 2017.

40.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003. Review.

41.

Vitamin K deficiency: the linking pin between COPD and cardiovascular diseases?

Piscaer I, Wouters EFM, Vermeer C, Janssens W, Franssen FME, Janssen R.

Respir Res. 2017 Nov 13;18(1):189. doi: 10.1186/s12931-017-0673-z. Review.

42.

High intensity training in obesity: a Meta-analysis.

Türk Y, Theel W, Kasteleyn MJ, Franssen FME, Hiemstra PS, Rudolphus A, Taube C, Braunstahl GJ.

Obes Sci Pract. 2017 May 29;3(3):258-271. doi: 10.1002/osp4.109. eCollection 2017 Sep. Review.

43.

The patient with a complex chronic respiratory disease: a specialist of his own life?

Houben-Wilke S, Augustin IM, Wouters BB, Stevens RA, Janssen DJ, Spruit MA, Vanfleteren LE, Franssen FM, Wouters EF.

Expert Rev Respir Med. 2017 Dec;11(12):919-924. doi: 10.1080/17476348.2017.1392242. Epub 2017 Oct 25.

PMID:
29025350
44.

Endothelial function in patients with chronic obstructive pulmonary disease: a systematic review of studies using flow mediated dilatation.

Vaes AW, Spruit MA, Theunis J, Goswami N, Vanfleteren LE, Franssen FME, Wouters EFM, De Boever P.

Expert Rev Respir Med. 2017 Dec;11(12):1021-1031. doi: 10.1080/17476348.2017.1389277. Epub 2017 Oct 12. Review.

PMID:
28978239
45.

Raw BIA variables are predictors of muscle strength in patients with chronic obstructive pulmonary disease.

de Blasio F, Santaniello MG, de Blasio F, Mazzarella G, Bianco A, Lionetti L, Franssen FME, Scalfi L.

Eur J Clin Nutr. 2017 Nov;71(11):1336-1340. doi: 10.1038/ejcn.2017.147. Epub 2017 Sep 13.

PMID:
28901331
46.

Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.

Braeken DC, Rohde GG, Franssen FM, Driessen JH, van Staa TP, Souverein PC, Wouters EF, de Vries F.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 14;12:2425-2432. doi: 10.2147/COPD.S138435. eCollection 2017.

47.

Should resistance training be targeted to a specific subgroup of patients with non-small cell lung cancer? - Reply.

Burtin C, Franssen FME, Spruit MA.

Respirology. 2017 Oct;22(7):1474. doi: 10.1111/resp.13129. Epub 2017 Jul 20. No abstract available.

PMID:
28727273
48.

Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.

Oshagbemi OA, Driessen JHM, Pieffers A, Wouters EFM, Geusens P, Vestergaard P, van den Bergh J, Franssen FME, de Vries F.

Osteoporos Int. 2017 Oct;28(10):2859-2866. doi: 10.1007/s00198-017-4115-z. Epub 2017 Jun 21.

49.

A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD.

van de Bool C, Rutten EPA, van Helvoort A, Franssen FME, Wouters EFM, Schols AMWJ.

J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):748-758. doi: 10.1002/jcsm.12219. Epub 2017 Jun 12.

50.

Changes in lower limb muscle function and muscle mass following exercise-based interventions in patients with chronic obstructive pulmonary disease: A review of the English-language literature.

De Brandt J, Spruit MA, Hansen D, Franssen FM, Derave W, Sillen MJ, Burtin C.

Chron Respir Dis. 2018 May;15(2):182-219. doi: 10.1177/1479972317709642. Epub 2017 Jun 5. Review.

Supplemental Content

Loading ...
Support Center